Ensign Peak Advisors, Inc Regenxbio Inc. Transaction History

Ensign Peak Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $100,282 - $157,644	4,499 Added 6.61%	72,610 $1.92 Million
Q2 2022 Aug 12, 2022	BUY	$19.35 - $35.04 $898,633 - $1.63 Million	46,441 Added 214.31%	68,111 $1.68 Million
Q4 2021 Feb 11, 2022	SELL	$30.19 - $40.28 $284,691 - $379,840	-9,430 Reduced 30.32%	21,670 $709,000
Q1 2020 May 11, 2020	BUY	$21.5 - $54.2 $94,600 - $238,480	4,400 Added 16.48%	31,100 $1.01 Million
Q4 2019 Feb 14, 2020	BUY	$34.54 - $44.87 $922,218 - $1.2 Million	26,700 New	26,700 $1.09 Million

193

42.1M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $460M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.